NovaBay
Pharmaceuticals NBY today announced
that it has received 510k clearance from the Food and Drug Administration to market NeutroPhase® Skin and Wound Cleanser under widened indications
including the moistening and debriding of graft and donor sites. Concurrently,
the FDA cleared NeutroPhase to be administered through a new convenient spray
pump.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in